# Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer

> **NCT06198387** · NA · NOT_YET_RECRUITING · sponsor: **Changhai Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Oligo-metastatic Prostate Carcinoma

## Interventions

- **RADIATION:** hormone and RT
- **DRUG:** ADT combined with abiraterone

## Key facts

- **NCT ID:** NCT06198387
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2025-09-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06198387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06198387, "Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06198387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*